Dow Down 0.17% Nasdaq Down 0.28%

ChemoCentryx, Inc. (CCXI)

-NMS
4.50 Down 0.05(1.10%) Sep 30, 4:00PM EDT
Prev Close:4.55
Open:4.53
Bid:N/A
Ask:5.30 x 1000
1y Target Est:6.50
Beta:1.19
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.48 - 4.82
52wk Range:4.41 - 8.25
Volume:190,350
Avg Vol (3m):85,181
Market Cap:195.01M
P/E (ttm):N/A
EPS (ttm):-1.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CCXI

Comparison

Symbol% ChgMkt Cap
CCXIDown 1.10%195.01M
ABTDown 0.74%62.54B
AMGNUp 0.28%106.69B
AZNDown 0.71%90.23B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):87.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.14
Quarterly EPS Est (Sep-14) :-0.28
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback